Literature DB >> 26225358

Can Genetic Testing Provide Information to Develop Customized Nutrigenomic Solutions for Reward Deficiency Syndrome?

Kenneth Blum1, Rajendra D Badgaiyan2, Zsolt Demotrovics3, James Fratantonio3, Gozde Agan4, Marcelo Febo4.   

Abstract

Entities:  

Year:  2015        PMID： 26225358      PMCID： PMC4516390          DOI： 10.23937/2378-3656/1410018

Source DB:  PubMed          Journal:  Clin Med Rev Case Rep        ISSN： 2378-3656


× No keyword cloud information.
  16 in total

1.  rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts.

Authors:  Kenneth Blum; Yijun Liu; Wei Wang; Yarong Wang; Yi Zhang; Marlene Oscar-Berman; Andrew Smolen; Marcelo Febo; David Han; Thomas Simpatico; Frans J Cronjé; Zsolt Demetrovics; Mark S Gold
Journal:  Postgrad Med       Date:  2014-12-16       Impact factor: 3.840

2.  "Liking" and "wanting" linked to Reward Deficiency Syndrome (RDS): hypothesizing differential responsivity in brain reward circuitry.

Authors:  Kenneth Blum; Eliot Gardner; Marlene Oscar-Berman; Mark Gold
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 3.  The D2 dopamine receptor gene as a determinant of reward deficiency syndrome.

Authors:  K Blum; P J Sheridan; R C Wood; E R Braverman; T J Chen; J G Cull; D E Comings
Journal:  J R Soc Med       Date:  1996-07       Impact factor: 18.000

Review 4.  Hypothesizing that brain reward circuitry genes are genetic antecedents of pain sensitivity and critical diagnostic and pharmacogenomic treatment targets for chronic pain conditions.

Authors:  Amanda L-C Chen; Thomas J H Chen; Roger L Waite; Jeffrey Reinking; Howard L Tung; Patrick Rhoades; B William Downs; Eric Braverman; Dasha Braverman; Mallory Kerner; Seth H Blum; Nicholas DiNubile; David Smith; Marlene Oscar-Berman; Thomas J Prihoda; John B Floyd; David O'Brien; H H Liu; Kenneth Blum
Journal:  Med Hypotheses       Date:  2008-10-31       Impact factor: 1.538

5.  LG839: anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome.

Authors:  Kenneth Blum; Amanda L C Chen; Thomas J H Chen; Patrick Rhoades; Thomas J Prihoda; B William Downs; Roger L Waite; Lonna Williams; Eric R Braverman; Dasha Braverman; Vanessa Arcuri; Mallory Kerner; Seth H Blum; Tomas Palomo
Journal:  Adv Ther       Date:  2008-09       Impact factor: 3.845

6.  Neurogenetic Impairments of Brain Reward Circuitry Links to Reward Deficiency Syndrome (RDS): Potential Nutrigenomic Induced Dopaminergic Activation.

Authors:  K Blum; M Oscar-Berman; J Giordano; Bw Downs; T Simpatico; D Han; John Femino
Journal:  J Genet Syndr Gene Ther       Date:  2012-10-17

7.  Coupling Genetic Addiction Risk Score (GARS) with Electrotherapy: Fighting Iatrogenic Opioid Dependence.

Authors:  Kenneth Blum; Marlene Oscar-Berman; Nicholas Dinubile; John Giordano; Eric R Braverman; Courtney E Truesdell; Debmalya Barh; Rajendra Badgaiyan
Journal:  J Addict Res Ther       Date:  2013-10-31

Review 8.  Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubric.

Authors:  Kenneth Blum; Marcelo Febo; Thomas McLaughlin; Frans J Cronjé; David Han; S Mark Gold
Journal:  J Behav Addict       Date:  2014-08-26       Impact factor: 6.756

9.  Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS).

Authors:  Kenneth Blum; Marlene Oscar-Berman; Zsolt Demetrovics; Debmalya Barh; Mark S Gold
Journal:  Mol Neurobiol       Date:  2014-05-31       Impact factor: 5.590

10.  Linking online gaming and addictive behavior: converging evidence for a general reward deficiency in frequent online gamers.

Authors:  Tim Hahn; Karolien Hilde Notebaert; Thomas Dresler; Linda Kowarsch; Andreas Reif; Andreas J Fallgatter
Journal:  Front Behav Neurosci       Date:  2014-11-10       Impact factor: 3.558
View more
  4 in total

1.  Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

Authors:  Kenneth Blum; Edward J Modestino; Rajendra D Badgaiyan; David Baron; Panayotis K Thanos; Igor Elman; David Siwicki; Marcelo Febo; Mark S Gold
Journal:  EC Psychol Psychiatr       Date:  2018-07-30

2.  Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD).

Authors:  Kenneth Blum; Margaret A Madigan; Lyle Fried; Eric R Braverman; John Giordano; Rajendra D Badgaiyan
Journal:  Glob J Addict Rehabil Med       Date:  2017-02-23

3.  Should the United States Government Repeal Restrictions on Buprenorphine/Naloxone Treatment?

Authors:  Kenneth Blum; Mark Gold; H Westley Clark; Kristina Dushaj; Rajendra D Badgaiyan
Journal:  Subst Use Misuse       Date:  2016-07-27       Impact factor: 2.164

4.  Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z.

Authors:  Marcelo Febo; Kenneth Blum; Rajendra D Badgaiyan; Pablo D Perez; Luis M Colon-Perez; Panayotis K Thanos; Craig F Ferris; Praveen Kulkarni; John Giordano; David Baron; Mark S Gold
Journal:  PLoS One       Date:  2017-04-26       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.